Hemolytic-Uremic Syndrome clinical trials at UC Irvine
1 research study open to eligible people
Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of Crovalimab in Adult and Adolescent Participants With Atypical Hemolytic Uremic Syndrome (aHUS)
open to eligible people ages 12 years and up
This study aims to evaluate the efficacy and safety of crovalimab in adult and adolescent participants with aHUS.
Orange, California and other locations